Parenteral Nutrition Global Market Report 2024

The parenteral nutrition market size has grown strongly in recent years. It will grow from $6.48 billion in 2023 to $6.85 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The increase in the historical period can be ascribed to the upsurge in disposable income and urbanization, a rise in the obese population, and the growing popularity of noninvasive and minimally invasive aesthetic procedures.

The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $8.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The expansion anticipated in the forecast period can be linked to a growing elderly population, swift urbanization, an upswing in disposable income, and a surge in mergers and acquisitions. Key trends expected in the forecast period encompass product innovations, the integration of artificial intelligence in aesthetics, the advancement of focal radio frequency technology, the adoption of laser-assisted liposuction, and an increase in partnerships and collaborations.

The increasing prevalence of malnutrition worldwide is a key factor driving the expansion of the parenteral nutrition market. Malnutrition encompasses deficiencies, excesses, or imbalances in an individual's intake of energy or nutrients. The demand for parenteral nutrition has risen, particularly among children and infants born prematurely, leading to immune dysfunction and inadequate nutrition. In 2021, the World Health Organization reported that 1.9 billion adults were overweight or obese, and 462 million were underweight. About 45% of deaths in children under 5 years old are associated with undernutrition. Consequently, the global increase in malnutrition is anticipated to fuel the demand for parenteral nutrition in the forecast period.

The growth of the parenteral nutrition market is also expected to be propelled by the rising birth rate. Birth rate denotes the proportion of live births in the general population per 1,000 people annually. The surge in birth rates and fertility rates is a significant indicator of an increased malnutrition burden among women of childbearing age and new mothers, consequently boosting the demand for parenteral nutrition. For instance, in July 2022, the United Nations reported a 0.09% increase in the US birth rate, reaching 12.012 births per 1000 people in 2022 compared to 2020. Therefore, the escalating birth rate is poised to drive the growth of the parenteral nutrition market.

Product innovation stands out as a prominent trend in the parenteral nutrition market. Companies in this market are introducing innovative products, such as the four-oil lipid injectable emulsion, to diversify their parenteral nutrition portfolios. For example, in March 2022, Fresenius Kabi received approval from the US FDA for SMOFlipid lipid injectable emulsion, the first and only four-oil lipid injectable emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil. This product, beneficial for its omega-3 fatty acids, is suitable for pediatric parenteral nutrition, including term and preterm neonates, in both hospital and home care settings.

Companies in the parenteral nutrition market are also concentrating on the introduction of glass packaging systems featuring innovative technologies such as SG EZ-fill packaging technology. Glass packaging systems, known for their chemical inertness and ease of sterilization, guarantee prolonged sterility while safeguarding the physical integrity of the product. In March 2022, SGD Pharma introduced ready-to-use sterile 100 ml Type 1 molded glass vials in SG EZ-fill packaging technology for aseptic fill/finish of parenteral products. The advantages of SG EZ-fill packaging technology include minimal glass-to-glass contact, reducing particle generation to ensure patient safety and minimizing the risk of contamination.

In October 2021, Wellspring Capital Management, a New York-based private equity firm, acquired Pentec Health Inc., a US-based provider of intradialytic parenteral nutrition and targeted drug delivery therapies, for an undisclosed amount. Wellspring's acquisition aims to strengthen its position in the specialty infusion sector and accelerate its inorganic and organic growth initiatives.

Major companies operating in the parenteral nutrition market report are Baxter International Inc., Fresenius SE & Co. KGaA, Otsuka Pharmaceutical Factory Inc., B. Braun, Sichuan Kelun Pharmaceutical Co. Ltd., American Regent Inc., JW Pharmaceutical, Grifols S.A., Amanta Healthcare, ICU Medical Inc., Hubei Provincial Bafeng Pharmaceuticals and Chemicals Share Co. Ltd., Allergan, Vifor Pharma, Pharmasyntez, Horatev, Soleo Health, Enteris BioPharma, Allena Pharmaceuticals, AbbVie, Johnson & Johnson, Sanofi, Biogen Inc., Farmoterápica, Pfizer Inc., Actavis Inc.

North America was the largest region in the parenteral nutrition market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the parenteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The key components utilized in parenteral nutrition comprise amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other elements. Amino acids-based parenteral nutrition pertains to products derived from amino acids for parenteral nutrition. Amino acids serve as a fundamental element in complete parenteral nutrition prescriptions, supporting functions such as cell, organ, skeletal, and respiratory muscle functions, as well as wound healing. These are applicable to adults, children, and newborns in various healthcare settings, including hospitals, clinics, home care, and other end-users.

The parenteral nutrition market research report is one of a series of new reports that provides parenteral nutrition market statistics, including parenteral nutrition industry global market size, regional shares, competitors with a parenteral nutrition market share, detailed parenteral nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. This parenteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.